Introduction and Chairman's Overview
Craig M. Kessler, MD

Clotting, Cancer, and Controversies: What the Trials, Emerging Science, and Current Thinking Tell Us About The Evolving Science and Foundation Role of Anticoagulation in the Setting of Cancer
Craig M. Kessler, MD

Cancer, Thrombosis, and The Biology of Malignancy: A Science-to-Clinical Strategy Perspective — The Role of LMWHs at the Interface of Thrombosis and Cancer
Frederick Rickles, MD, FACP

Thrombosis Prophylaxis, Monitoring, and Management in the Setting of Cancer: Critical Challenges, Identifying Patients at Risk—What Do Landmark Trials Teach Us About Optimizing Patient Care?
Craig M. Kessler, MD

VTE Prophylaxis in the Cancer Patient and Beyond: Guidelines, Alerts, Evidence-Based Therapeutics, and Implications for Day-to-Day Practice
Samuel Z. Goldhaber, MD

Question and Answer Session
Faculty Panel